Michael Ackermann Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity
Michael Ackermann is Director of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.21 Million shares of TARS, which is worth approximately $66.5 Million. The most recent transaction as insider was on Jun 15, 2022, when has been sold 4,257 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.21M
0%
3M change
0%
12M change
Total Value Held
$66.5 Million
Michael Ackermann Transaction History
MA
Michael Ackermann
Director
Irvine, CA